ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Return
4.95%
This Quarter Return
+2.4%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$370M
AUM Growth
+$40.8M
(+12%)
Cap. Flow
+$91.4M
Cap. Flow
% of AUM
24.72%
Top 10 Holdings %
Top 10 Hldgs %
53.19%
Holding
85
New
33
Increased
12
Reduced
20
Closed
17
Top Buys
| 1 |
AstraZeneca
AZN
|
$18.9M |
| 2 |
Sanofi
SNY
|
$18.5M |
| 3 |
Labcorp
LH
|
$14.6M |
| 4 |
Cencora
COR
|
$12.4M |
| 5 |
Charles River Laboratories
CRL
|
$7M |
Top Sells
| 1 |
AbbVie
ABBV
|
$19.5M |
| 2 |
Bristol-Myers Squibb
BMY
|
$12.5M |
| 3 |
Icon
ICLR
|
$12.2M |
| 4 |
Johnson & Johnson
JNJ
|
$9.46M |
| 5 |
Owens & Minor
OMI
|
$7.88M |
Sector Composition
| 1 | Healthcare | 80.71% |
| 2 | Industrials | 1.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – |
0
| – | – |
|
77
Xenon Pharmaceuticals
XENE
$2.96B
| – | – |
-62,743
| Closed | -$959K |
|
|
KLRS
78
Kalaris Therapeutics, Inc. Common Stock
KLRS
$84.3M
| – | – |
-1,932
| Closed | -$1.11M |
|
|
PDCO
79
DELISTED
Patterson Companies, Inc.
PDCO
| – | – |
-26,799
| Closed | -$808K |
|
|
BLU
80
DELISTED
BELLUS Health Inc.
BLU
| – | – |
-389,833
| Closed | -$2.39M |
|
|
CYAD
81
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
| – | – |
-145,380
| Closed | -$596K |
|
|
IVC
82
DELISTED
Invacare Corporation
IVC
| – | – |
-1,146,068
| Closed | -$323K |
|
|
TRIL
83
DELISTED
Trillium Therapeutics Inc.
TRIL
| – | – |
0
| – | – |
|